APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydroxyprogesterone Caproate Injection

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.

Selected research

Market Outlook & Growth Opportunities

Global Hydroxyprogesterone Caproate Injection Market Outlook and Growth Opportunities 2026

31 December 2025191 pages

Choose your research edition.

Industry ResearchHydroxyprogesterone Caproate Injection Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxyprogesterone Caproate Injection Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Hydroxyprogesterone Caproate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxyprogesterone Caproate Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxyprogesterone Caproate Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.

Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.

This report provides an overview of the global Hydroxyprogesterone Caproate Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Hydroxyprogesterone Caproate Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hydroxyprogesterone Caproate Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hydroxyprogesterone Caproate Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Hydroxyprogesterone Caproate Injection Segment by Company

AMAG Pharmaceuticals

Mcguff Pharmaceuticals Inc

Aspen Oss B.V

American Regent, Inc.

Mylan Institutional

Hydroxyprogesterone Caproate Injection Segment by Type

1 mL Injection(Including 1.1 mL)

5 mL Injection

Hydroxyprogesterone Caproate Injection Segment by Application

Hospitals Injection

Clinics Injection

Hydroxyprogesterone Caproate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hydroxyprogesterone Caproate Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Hydroxyprogesterone Caproate Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hydroxyprogesterone Caproate Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Hydroxyprogesterone Caproate Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxyprogesterone Caproate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxyprogesterone Caproate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxyprogesterone Caproate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hydroxyprogesterone Caproate Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hydroxyprogesterone Caproate Injection industry.

Chapter 3: Detailed analysis of Hydroxyprogesterone Caproate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Hydroxyprogesterone Caproate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Hydroxyprogesterone Caproate Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hydroxyprogesterone Caproate Injection Industry Trends Table 2. Hydroxyprogesterone Caproate Injection Industry Drivers Table 3. Hydroxyprogesterone Caproate Injection Industry Opportunities and Challenges Table 4. Hydroxyprogesterone Caproate Injection Industry Restraints Table 5. Global Hydroxyprogesterone Caproate Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hydroxyprogesterone Caproate Injection Revenue Share by Company (2021-2026) Table 7. Global Hydroxyprogesterone Caproate Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Hydroxyprogesterone Caproate Injection Sales Volume Share by Company (2021-2026) Table 9. Global Hydroxyprogesterone Caproate Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Hydroxyprogesterone Caproate Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Hydroxyprogesterone Caproate Injection Key Company Manufacturing Base & Headquarters Table 12. Global Hydroxyprogesterone Caproate Injection Company, Product Type & Application Table 13. Global Hydroxyprogesterone Caproate Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Hydroxyprogesterone Caproate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 1 mL Injection(Including 1.1 mL) Table 18. Significant Companies of 5 mL Injection Table 19. Global Hydroxyprogesterone Caproate Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Hydroxyprogesterone Caproate Injection Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Hydroxyprogesterone Caproate Injection Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Hydroxyprogesterone Caproate Injection Sales Volume Share by Type (2021-2026) Table 23. Global Hydroxyprogesterone Caproate Injection Sales Volume Share by Type (2027-2032) Table 24. Global Hydroxyprogesterone Caproate Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Hydroxyprogesterone Caproate Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Hydroxyprogesterone Caproate Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Hydroxyprogesterone Caproate Injection Sales Value Share by Type (2021-2026) Table 28. Global Hydroxyprogesterone Caproate Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Injection Table 30. Significant Companies of Clinics Injection Table 31. Global Hydroxyprogesterone Caproate Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Hydroxyprogesterone Caproate Injection Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Hydroxyprogesterone Caproate Injection Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Hydroxyprogesterone Caproate Injection Sales Volume Share by Application (2021-2026) Table 35. Global Hydroxyprogesterone Caproate Injection Sales Volume Share by Application (2027-2032) Table 36. Global Hydroxyprogesterone Caproate Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Hydroxyprogesterone Caproate Injection Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Hydroxyprogesterone Caproate Injection Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Hydroxyprogesterone Caproate Injection Sales Value Share by Application (2021-2026) Table 40. Global Hydroxyprogesterone Caproate Injection Sales Value Share by Application (2027-2032) Table 41. Global Hydroxyprogesterone Caproate Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Hydroxyprogesterone Caproate Injection Sales by Region (2021-2026) & (K Units) Table 43. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2021-2026) Table 44. Global Hydroxyprogesterone Caproate Injection Sales by Region (2027-2032) & (K Units) Table 45. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2027-2032) Table 46. Global Hydroxyprogesterone Caproate Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Hydroxyprogesterone Caproate Injection Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Hydroxyprogesterone Caproate Injection Sales Value Share by Region (2021-2026) Table 49. Global Hydroxyprogesterone Caproate Injection Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Hydroxyprogesterone Caproate Injection Sales Value Share by Region (2027-2032) Table 51. Global Hydroxyprogesterone Caproate Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Hydroxyprogesterone Caproate Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Hydroxyprogesterone Caproate Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Hydroxyprogesterone Caproate Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026) & (K Units) Table 56. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2021-2026) Table 57. Global Hydroxyprogesterone Caproate Injection Sales by Country (2027-2032) & (K Units) Table 58. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2027-2032) Table 59. Global Hydroxyprogesterone Caproate Injection Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Hydroxyprogesterone Caproate Injection Sales Value Market Share by Country (2021-2026) Table 61. Global Hydroxyprogesterone Caproate Injection Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Hydroxyprogesterone Caproate Injection Sales Value Market Share by Country (2027-2032) Table 63. AMAG Pharmaceuticals Company Information Table 64. AMAG Pharmaceuticals Business Overview Table 65. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolio Table 67. AMAG Pharmaceuticals Recent Development Table 68. Mcguff Pharmaceuticals Inc Company Information Table 69. Mcguff Pharmaceuticals Inc Business Overview Table 70. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolio Table 72. Mcguff Pharmaceuticals Inc Recent Development Table 73. Aspen Oss B.V Company Information Table 74. Aspen Oss B.V Business Overview Table 75. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolio Table 77. Aspen Oss B.V Recent Development Table 78. American Regent, Inc. Company Information Table 79. American Regent, Inc. Business Overview Table 80. American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolio Table 82. American Regent, Inc. Recent Development Table 83. Mylan Institutional Company Information Table 84. Mylan Institutional Business Overview Table 85. Mylan Institutional Hydroxyprogesterone Caproate Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolio Table 87. Mylan Institutional Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Hydroxyprogesterone Caproate Injection Distributors List Table 91. Hydroxyprogesterone Caproate Injection Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Hydroxyprogesterone Caproate Injection Product Image Figure 2. Global Hydroxyprogesterone Caproate Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxyprogesterone Caproate Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Hydroxyprogesterone Caproate Injection Sales (2021-2032) & (K Units) Figure 5. Global Hydroxyprogesterone Caproate Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Hydroxyprogesterone Caproate Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 1 mL Injection(Including 1.1 mL) Image Figure 10. 5 mL Injection Image Figure 11. Global Hydroxyprogesterone Caproate Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Hydroxyprogesterone Caproate Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Hydroxyprogesterone Caproate Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Hydroxyprogesterone Caproate Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Hydroxyprogesterone Caproate Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Hydroxyprogesterone Caproate Injection Sales Value Share by Type (2021-2032) Figure 17. Hospitals Injection Image Figure 18. Clinics Injection Image Figure 19. Global Hydroxyprogesterone Caproate Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Hydroxyprogesterone Caproate Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Hydroxyprogesterone Caproate Injection Sales Volume Share by Application (2021-2032) Figure 22. Global Hydroxyprogesterone Caproate Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Hydroxyprogesterone Caproate Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Hydroxyprogesterone Caproate Injection Sales Value Share by Application (2021-2032) Figure 25. Global Hydroxyprogesterone Caproate Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Hydroxyprogesterone Caproate Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Hydroxyprogesterone Caproate Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Hydroxyprogesterone Caproate Injection Sales Value (2021-2032) & (US$ Million) Figure 30. North America Hydroxyprogesterone Caproate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Hydroxyprogesterone Caproate Injection Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Hydroxyprogesterone Caproate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Hydroxyprogesterone Caproate Injection Sales Value (2021-2032) & (US$ Million) Figure 36. South America Hydroxyprogesterone Caproate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Hydroxyprogesterone Caproate Injection Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Hydroxyprogesterone Caproate Injection Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 1 mL Injection(Including 1.1 mL)
  • 5 mL Injection
Applications
  • Hospitals Injection
  • Clinics Injection
Companies covered
  • AMAG Pharmaceuticals
  • Mcguff Pharmaceuticals Inc
  • Aspen Oss B.V
  • American Regent, Inc.
  • Mylan Institutional

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hydroxyprogesterone Caproate Injection Sales Value (2021-2032)
  4. 1.2.2 Global Hydroxyprogesterone Caproate Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Hydroxyprogesterone Caproate Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Hydroxyprogesterone Caproate Injection Market Dynamics
  1. 2.1 Hydroxyprogesterone Caproate Injection Industry Trends
  2. 2.2 Hydroxyprogesterone Caproate Injection Industry Drivers
  3. 2.3 Hydroxyprogesterone Caproate Injection Industry Opportunities and Challenges
  4. 2.4 Hydroxyprogesterone Caproate Injection Industry Restraints
3 Hydroxyprogesterone Caproate Injection Market by Company
  1. 3.1 Global Hydroxyprogesterone Caproate Injection Company Revenue Ranking in 2025
  2. 3.2 Global Hydroxyprogesterone Caproate Injection Revenue by Company (2021-2026)
  3. 3.3 Global Hydroxyprogesterone Caproate Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Hydroxyprogesterone Caproate Injection Average Price by Company (2021-2026)
  5. 3.5 Global Hydroxyprogesterone Caproate Injection Company Ranking (2024-2026)
  6. 3.6 Global Hydroxyprogesterone Caproate Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Hydroxyprogesterone Caproate Injection Company Product Type and Application
  8. 3.8 Global Hydroxyprogesterone Caproate Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Hydroxyprogesterone Caproate Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Hydroxyprogesterone Caproate Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Hydroxyprogesterone Caproate Injection Market by Type
  1. 4.1 Hydroxyprogesterone Caproate Injection Type Introduction
  2. 4.1.1 1 mL Injection(Including 1.1 mL)
  3. 4.1.2 5 mL Injection
  4. 4.2 Global Hydroxyprogesterone Caproate Injection Sales Volume by Type
  5. 4.2.1 Global Hydroxyprogesterone Caproate Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hydroxyprogesterone Caproate Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Hydroxyprogesterone Caproate Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Hydroxyprogesterone Caproate Injection Sales Value by Type
  9. 4.3.1 Global Hydroxyprogesterone Caproate Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hydroxyprogesterone Caproate Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Hydroxyprogesterone Caproate Injection Sales Value Share by Type (2021-2032)
5 Hydroxyprogesterone Caproate Injection Market by Application
  1. 5.1 Hydroxyprogesterone Caproate Injection Application Introduction
  2. 5.1.1 Hospitals Injection
  3. 5.1.2 Clinics Injection
  4. 5.2 Global Hydroxyprogesterone Caproate Injection Sales Volume by Application
  5. 5.2.1 Global Hydroxyprogesterone Caproate Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hydroxyprogesterone Caproate Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Hydroxyprogesterone Caproate Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Hydroxyprogesterone Caproate Injection Sales Value by Application
  9. 5.3.1 Global Hydroxyprogesterone Caproate Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hydroxyprogesterone Caproate Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Hydroxyprogesterone Caproate Injection Sales Value Share by Application (2021-2032)
6 Hydroxyprogesterone Caproate Injection Regional Sales and Value Analysis
  1. 6.1 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hydroxyprogesterone Caproate Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Hydroxyprogesterone Caproate Injection Sales by Region (2027-2032)
  5. 6.3 Global Hydroxyprogesterone Caproate Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Hydroxyprogesterone Caproate Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Hydroxyprogesterone Caproate Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Hydroxyprogesterone Caproate Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Hydroxyprogesterone Caproate Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Hydroxyprogesterone Caproate Injection Sales Value (2021-2032)
  12. 6.6.2 North America Hydroxyprogesterone Caproate Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Hydroxyprogesterone Caproate Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Hydroxyprogesterone Caproate Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Hydroxyprogesterone Caproate Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Hydroxyprogesterone Caproate Injection Sales Value (2021-2032)
  21. 6.9.2 South America Hydroxyprogesterone Caproate Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Value Share by Country, 2025 VS 2032
7 Hydroxyprogesterone Caproate Injection Country-level Sales and Value Analysis
  1. 7.1 Global Hydroxyprogesterone Caproate Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hydroxyprogesterone Caproate Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Hydroxyprogesterone Caproate Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Hydroxyprogesterone Caproate Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Hydroxyprogesterone Caproate Injection Sales by Country (2027-2032)
  6. 7.4 Global Hydroxyprogesterone Caproate Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Hydroxyprogesterone Caproate Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Hydroxyprogesterone Caproate Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Hydroxyprogesterone Caproate Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Hydroxyprogesterone Caproate Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Hydroxyprogesterone Caproate Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AMAG Pharmaceuticals
  2. 8.1.1 AMAG Pharmaceuticals Company Information
  3. 8.1.2 AMAG Pharmaceuticals Business Overview
  4. 8.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolio
  6. 8.1.5 AMAG Pharmaceuticals Recent Developments
  7. 8.2 Mcguff Pharmaceuticals Inc
  8. 8.2.1 Mcguff Pharmaceuticals Inc Company Information
  9. 8.2.2 Mcguff Pharmaceuticals Inc Business Overview
  10. 8.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolio
  12. 8.2.5 Mcguff Pharmaceuticals Inc Recent Developments
  13. 8.3 Aspen Oss B.V
  14. 8.3.1 Aspen Oss B.V Company Information
  15. 8.3.2 Aspen Oss B.V Business Overview
  16. 8.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolio
  18. 8.3.5 Aspen Oss B.V Recent Developments
  19. 8.4 American Regent, Inc.
  20. 8.4.1 American Regent, Inc. Company Information
  21. 8.4.2 American Regent, Inc. Business Overview
  22. 8.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolio
  24. 8.4.5 American Regent, Inc. Recent Developments
  25. 8.5 Mylan Institutional
  26. 8.5.1 Mylan Institutional Company Information
  27. 8.5.2 Mylan Institutional Business Overview
  28. 8.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolio
  30. 8.5.5 Mylan Institutional Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hydroxyprogesterone Caproate Injection Value Chain Analysis
  2. 9.1.1 Hydroxyprogesterone Caproate Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hydroxyprogesterone Caproate Injection Sales Mode & Process
  6. 9.2 Hydroxyprogesterone Caproate Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hydroxyprogesterone Caproate Injection Distributors
  9. 9.2.3 Hydroxyprogesterone Caproate Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst